Concepedia

David Hoffmann

DH

Statistics

Publications

9

Citations

813

H-Index

9

Active since

1981

Affiliations

Institute of Molecular Biotechnology(Current)

Vienna Biocenter

Austrian Academy of Sciences

University of British Columbia

Research Institute of Molecular Pathology

David Hoffmann is an author at Institute of Molecular Biotechnology specializing in life sciences, molecular biology, and cell biology.

ORCID

Publications per year

1981–2021

9

Publications

9

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

Shane J. F. Cronin, Corey R. Seehus, Adelheid Weidinger et al. · Nature · 2018 · 287 citations · Full text

, , +11

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

Lisa Haas, Anais Elewaut, Camille L. Gérard et al. · Nature Cancer · 2021 · 196 citations · Full text

, , +14

Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy

Iris Uribesalgo, David Hoffmann, Yin Zhang et al. · EMBO Molecular Medicine · 2019 · 106 citations · Full text

, , +15

Identification of lectin receptors for conserved SARS‐CoV‐2 glycosylation sites

David Hoffmann, Stefan Mereiter, Yoo Jin Oh et al. · The EMBO Journal · 2021 · 77 citations · Full text

, , +17

Megakaryocytes use in vivo podosome‐like structures working collectively to penetrate the endothelial barrier of bone marrow sinusoids

Anita Eckly, Cyril Scandola, Antoine Oprescu et al. · Journal of Thrombosis and Haemostasis · 2020 · 56 citations

, , +10

1–5 of 9